24.06.2024 13:15:52 - dpa-AFX: *BIONTECH, DUALITYBIO RECEIVE FDA FAST TRACK DESIGNATION FOR BNT324/DB-1311 IN PROSTATE CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BIONTECH SE SPON. ADRS 1 A2PSR2 Xetra 79,250 19.07.24 15:24:54 -0,900 -1,12% 79,100 79,400 79,450 80,150

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH